Plus Therapeutics granted 180-day to regain compliance with Nasdaq
Plus TherapeuticsPlus Therapeutics(US:PSTV) Seeking Alpha·2025-11-17 13:06

Group 1 - The article does not provide any specific content related to a company or industry [1]